X-ray diffraction studies using a novel synthetic phospholipid

A. J. Cudmore, J. P. Bradshaw, M. R. Alecio

Research output: Contribution to journalArticle

Abstract

A novel brominated phospholipid has been designed and synthesised for future use in X-ray diffraction studies. It is an analogue of dipalmitoyl-phosphatidylcholine (DPPC), with the sn-2 chain terminal methyl group exchanged for a bromine atom. This bromine atom "label" has been incorporated into a phospholipid by substitution for a group of similar atomic radius, 1.85 versus 2.00 Å, thus creating a molecule which is sterically similar to its unlabelled analogue. The "bromolipid" has been studied using the swelling series method in conjunction with Patterson mapping in the gel phase at 20°C. It diffracts well to 12 orders in its pure form at 20°C and between 57% and 98% relative humidity. A combination of two phasing methods have allowed the diffraction patterns of bilayers incorporating the bromolipid to be phased unambiguously. We suggest that the bromolipid is excellently suited as a phasing agent for use in future isomorphous replacement and multiple anomalous diffraction (MAD) experiments.

Original languageEnglish
Pages (from-to)71-76
Number of pages6
JournalBiophysical Chemistry
Volume49
Issue number1
DOIs
Publication statusPublished - 1994

Keywords

  • Bromolipid
  • Patterson mapping
  • Phospholipid
  • X-ray diffraction

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Organic Chemistry

Cite this

X-ray diffraction studies using a novel synthetic phospholipid. / Cudmore, A. J.; Bradshaw, J. P.; Alecio, M. R.

In: Biophysical Chemistry, Vol. 49, No. 1, 1994, p. 71-76.

Research output: Contribution to journalArticle

Cudmore, A. J. ; Bradshaw, J. P. ; Alecio, M. R. / X-ray diffraction studies using a novel synthetic phospholipid. In: Biophysical Chemistry. 1994 ; Vol. 49, No. 1. pp. 71-76.
@article{4a41b71e77b044d3abebfdb01fedab22,
title = "X-ray diffraction studies using a novel synthetic phospholipid",
abstract = "A novel brominated phospholipid has been designed and synthesised for future use in X-ray diffraction studies. It is an analogue of dipalmitoyl-phosphatidylcholine (DPPC), with the sn-2 chain terminal methyl group exchanged for a bromine atom. This bromine atom {"}label{"} has been incorporated into a phospholipid by substitution for a group of similar atomic radius, 1.85 versus 2.00 {\AA}, thus creating a molecule which is sterically similar to its unlabelled analogue. The {"}bromolipid{"} has been studied using the swelling series method in conjunction with Patterson mapping in the gel phase at 20°C. It diffracts well to 12 orders in its pure form at 20°C and between 57{\%} and 98{\%} relative humidity. A combination of two phasing methods have allowed the diffraction patterns of bilayers incorporating the bromolipid to be phased unambiguously. We suggest that the bromolipid is excellently suited as a phasing agent for use in future isomorphous replacement and multiple anomalous diffraction (MAD) experiments.",
keywords = "Bromolipid, Patterson mapping, Phospholipid, X-ray diffraction",
author = "Cudmore, {A. J.} and Bradshaw, {J. P.} and Alecio, {M. R.}",
year = "1994",
doi = "10.1016/0301-4622(93)E0083-H",
language = "English",
volume = "49",
pages = "71--76",
journal = "Biophysical Chemistry",
issn = "0301-4622",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - X-ray diffraction studies using a novel synthetic phospholipid

AU - Cudmore, A. J.

AU - Bradshaw, J. P.

AU - Alecio, M. R.

PY - 1994

Y1 - 1994

N2 - A novel brominated phospholipid has been designed and synthesised for future use in X-ray diffraction studies. It is an analogue of dipalmitoyl-phosphatidylcholine (DPPC), with the sn-2 chain terminal methyl group exchanged for a bromine atom. This bromine atom "label" has been incorporated into a phospholipid by substitution for a group of similar atomic radius, 1.85 versus 2.00 Å, thus creating a molecule which is sterically similar to its unlabelled analogue. The "bromolipid" has been studied using the swelling series method in conjunction with Patterson mapping in the gel phase at 20°C. It diffracts well to 12 orders in its pure form at 20°C and between 57% and 98% relative humidity. A combination of two phasing methods have allowed the diffraction patterns of bilayers incorporating the bromolipid to be phased unambiguously. We suggest that the bromolipid is excellently suited as a phasing agent for use in future isomorphous replacement and multiple anomalous diffraction (MAD) experiments.

AB - A novel brominated phospholipid has been designed and synthesised for future use in X-ray diffraction studies. It is an analogue of dipalmitoyl-phosphatidylcholine (DPPC), with the sn-2 chain terminal methyl group exchanged for a bromine atom. This bromine atom "label" has been incorporated into a phospholipid by substitution for a group of similar atomic radius, 1.85 versus 2.00 Å, thus creating a molecule which is sterically similar to its unlabelled analogue. The "bromolipid" has been studied using the swelling series method in conjunction with Patterson mapping in the gel phase at 20°C. It diffracts well to 12 orders in its pure form at 20°C and between 57% and 98% relative humidity. A combination of two phasing methods have allowed the diffraction patterns of bilayers incorporating the bromolipid to be phased unambiguously. We suggest that the bromolipid is excellently suited as a phasing agent for use in future isomorphous replacement and multiple anomalous diffraction (MAD) experiments.

KW - Bromolipid

KW - Patterson mapping

KW - Phospholipid

KW - X-ray diffraction

UR - http://www.scopus.com/inward/record.url?scp=0028127982&partnerID=8YFLogxK

U2 - 10.1016/0301-4622(93)E0083-H

DO - 10.1016/0301-4622(93)E0083-H

M3 - Article

VL - 49

SP - 71

EP - 76

JO - Biophysical Chemistry

JF - Biophysical Chemistry

SN - 0301-4622

IS - 1

ER -